Department of Pharmacy, Faculty of Health Sciences, UiT The Arctic University of Norway , Breivika, NO-9037 Tromsø, Norway.
Laboratory for Molecular Pharmacology, Department of Neuroscience and Pharmacology, Faculty of Health and Medical Sciences, The Panum Institute, University of Copenhagen , Blegdamsvej 3, DK-2200 Copenhagen, Denmark.
J Med Chem. 2015 Oct 22;58(20):8141-53. doi: 10.1021/acs.jmedchem.5b00987. Epub 2015 Oct 2.
We here report an experimentally verified binding mode for the known tripeptidomimetic CXCR4 antagonist KRH-1636 (1). A limited SAR study based on the three functionalities of 1 was first conducted, followed by site-directed mutagenesis studies. The receptor mapping showed that both the potency and affinity of 1 were dependent on the transmembrane residues His(113), Asp(171), Asp(262), and His(281) and also suggested the involvement of Tyr(45) and Gln(200) (potency) and Tyr(116) and Glu(288) (affinity). Molecular docking of 1 to an X-ray structure of CXCR4 showed that the l-Arg guanidino group of 1 forms polar interactions with His(113) and Asp(171) and the (pyridin-2-ylmethyl)amino moiety is anchored by Asp(262) and His(281), whereas the naphthalene ring is tightly packed in a hydrophobic subpocket formed by the aromatic side chains of Trp(94), Tyr(45), and Tyr(116). The detailed picture of ligand-receptor interactions provided here will assist in structure-based design and further development of small-molecule peptidomimetic CXCR4 antagonists.
我们在此报告了已知三肽拟态 CXCR4 拮抗剂 KRH-1636(1)的实验验证结合模式。首先进行了基于 1 的三种功能的有限 SAR 研究,随后进行了定点突变研究。受体定位表明,1 的效力和亲和力都依赖于跨膜残基 His(113)、Asp(171)、Asp(262)和 His(281),并提示 Tyr(45)和 Gln(200)(效力)和 Tyr(116)和 Glu(288)(亲和力)的参与。1 与 CXCR4 的 X 射线结构的分子对接表明,1 的 l-Arg 胍基与 His(113)和 Asp(171)形成极性相互作用,(吡啶-2-基甲基)氨基部分由 Asp(262)和 His(281)锚定,而萘环紧密堆积在由 Trp(94)、Tyr(45)和 Tyr(116)的芳族侧链形成的疏水性亚口袋中。这里提供的配体-受体相互作用的详细图片将有助于基于结构的小分子肽拟态 CXCR4 拮抗剂的设计和进一步开发。